Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation

Journal of the American Heart Association
Guizhi LiuGan-Xin Yan

Abstract

Although atrial fibrillation (AF) is the most common abnormal heart rhythm and its prevalence continues to rise, there is a marked paucity of effective and safe antiarrhythmic drugs for AF. This study was done to test whether combined use of dofetilide and mexiletine exhibits not only a synergistic effect on AF suppression but also a safer profile in drug-induced ventricular proarrhythmias. The effects of dofetilide plus mexiletine on atrial effective refractory period (ERP), AF inducibility, QT, and QT-related ventricular arrhythmias were studied using the isolated arterially perfused rabbit atrial and ventricular wedge preparations. Dofetilide or mexiletine alone mildly to moderately prolonged atrial ERP, but their combined use produced a markedly rate-dependent increase in atrial ERP. Dofetilide (3 nmol/L) plus mexiletine (10 μmol/L) increased the ERP by 28.2% from 72.2±5.7 to 92.8±5.9 ms (n=9, P<0.01) at a pacing rate of 0.5 Hz and by 94.5% from 91.7±5.2 to 178.3±12.0 ms (n=9, P<0.01) at 3.3 Hz. Dofetilide plus mexiletine strongly suppressed AF inducibility. On the other hand, dofetilide at 10 nmol/L produced marked QT and Tp-e prolongation, steeper QT-BCL and Tp-e-BCL slopes, and induced early afterdepolarizations and tors...Continue Reading

References

Jan 1, 1992·European Heart Journal·S S Gottlieb, M Weinberg
Nov 1, 1988·The Journal of Physiology·W R Giles, Y Imaizumi
Sep 6, 2000·British Journal of Clinical Pharmacology·M J AllenS D Oliver
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Aug 1, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Tengxian LiuGan-Xin Yan
Jul 10, 2007·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Mehmet K AktasToshio Akiyama
Jan 28, 2010·JAMA : the Journal of the American Medical Association·David J WilberUNKNOWN ThermoCool AF Trial Investigators
Mar 9, 2010·Drugs·Greg L Plosker
Mar 25, 2010·British Journal of Pharmacology·Hua Rong LuDavid J Gallacher
Mar 30, 2010·Heart Failure Clinics·Steven A LubitzPatrick T Ellinor
Oct 5, 2010·Journal of the American College of Cardiology·Alexander BurashnikovCharles Antzelevitch
Dec 28, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Donglin GuoGan-Xin Yan
Jan 18, 2012·Circulation·Peter Zimetbaum
Feb 22, 2012·European Journal of Clinical Investigation·Yen-Yu LuYi-Jen Chen
Jun 20, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Tengxian LiuGan-Xin Yan
Apr 13, 2013·Circulation. Arrhythmia and Electrophysiology·Yuanfeng GaoGan-Xin Yan
Jul 9, 2013·The American Journal of Cardiology·Susan ColillaXianchen Liu
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Feb 17, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Datun QiGan-Xin Yan
Aug 1, 2015·Circulation. Arrhythmia and Electrophysiology·James A ReiffelUNKNOWN HARMONY Investigators*
Aug 12, 2015·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Apr 9, 2016·Journal of Molecular and Cellular Cardiology·Nico HartmannSamuel Sossalla
May 20, 2016·Journal of Pharmacological and Toxicological Methods·Guizhi LiuGan-Xin Yan

❮ Previous
Next ❯

Citations

Jun 27, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Deborah L WolbretteGerald V Naccarelli

❮ Previous
Next ❯

Software Mentioned

SigmaPlot

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
Mehmet K AktasToshio Akiyama
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
D M RodenD Darbar
Journal of the American College of Cardiology
A M ChoyD M Roden
© 2022 Meta ULC. All rights reserved